Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02963285 · ClinicalTrials.gov registry record
Optimal Positioning of Nasopharyngeal Temp Probe
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 158
- Enrollment target
NCT02963285: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT02963285 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 158 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02963285 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the optimal range of insertion depths for a nasopharyngeal probe in anesthetized pediatric patients as a function of age.
Primary Outcome
Nasopharyngeal probe will be withdrawn incrementally, with 5 minutes to equilibrate at each depth.
Interventions
- OTHER Nasopharyngeal temperature probe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2017-06-09 |
| Est. Completion | 2021-08-03 |
What the finished NCT02963285 record still lists
NCT02963285 is an observational study that tracks outcomes without assigning an intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Nasopharyngeal temperature probe is the first listed.
NCT02963285 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02963285 about?
NCT02963285 is a clinical study titled "Optimal Positioning of Nasopharyngeal Temp Probe". The purpose of this study is to determine the optimal range of insertion depths for a nasopharyngeal probe in anesthetized pediatric patients as a function of age.
What is the current status of trial NCT02963285?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2017-06-09. Estimated completion is 2021-08-03.
What interventions are being tested in trial NCT02963285?
The interventions under investigation include: Nasopharyngeal temperature probe (OTHER).
Who is sponsoring clinical trial NCT02963285?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI